Portfolio Strategies’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Portfolio Strategies’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-300	Closed	-$11K	–	261
2018 Q2	$11K	Hold	300	–	–	0.01%	150
2018 Q1	$10K	Buy	+300	New	+$10.5K	0.01%	159

Other funds holding SBIO

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BCM

Barometer Capital Management Toronto, Ontario, Canada $292M AUM 86.78% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return

Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Portfolio Strategies's SBIO Position: Q3 2018 in Review

Portfolio Strategies sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q3 2018, closing a stake of 300 shares — an estimated $11K sold.

Portfolio Strategies first reported a position in SBIO in Q1 2018 and held it in 2 quarters. The position peaked at $11K in Q2 2018. 55 funds tracked by Wall St. Rank hold SBIO as of Q3 2018.

Portfolio Strategies reported no remaining ALPS Medical Breakthroughs ETF position as of Q3 2018 after selling out during the quarter.
Portfolio Strategies sold 300 ALPS Medical Breakthroughs ETF shares in Q3 2018, an estimated $11K.
Portfolio Strategies first reported a position in ALPS Medical Breakthroughs ETF in Q1 2018 and held it in 2 quarters.
Portfolio Strategies's ALPS Medical Breakthroughs ETF position peaked at $11K in Q2 2018.
55 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2018.

Based on Portfolio Strategies's 13F filing for Q3 2018, filed 19 Oct 2018.